| NCT ID | NCT07333027 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Friedrich-Alexander-Universität Erlangen-Nürnberg |
| Condition | Depression Disorder |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2026-02-05 |
| Primary Completion | 2027-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2026-02-05 with a primary completion date of 2027-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this prospective study is to better understand the link between loneliness and depression in the inpatient psychiatric treatment of depression. It aims to answer: Do lonely and not lonely persons benefit the same way from inpatient depression treatment? Is loneliness a clinical relevant factor in inpatient treatment of depression? What are the underlying biopsychosocial mechanisms? Participants will be asked to do some * self-report questionnaires * clinical interview * biosampling (blood, saliva, stool) at three main measurement timepoints (1. begin of inpatient treatment, 2. day of discharge, 3. three months after discharge).
Eligibility Criteria
Inclusion Criteria: * primary diagnosis of depression according to ICD-10 (F32 or F33), as diagnosed by a physician or clinical psychologist in conjunction with the M.I.N.I. Mini-International Neuropsychiatric Interview diagnostic tools * inpatient elective or emergency admission to one of the two psychiatric clinics; - age over 18 years * sufficient understanding of spoken and written German * informed voluntary consent Exclusion Criteria: * a current lack of capacity to provide consent (e.g., pronounced psychotic symptoms, stuporous depressive syndrome, and thought constriction to suicidality) * previous participation in the study * pregnancy or breastfeeding * inpatient stay of less than 7 days, even if the patients initially met the inclusion criteria.
Contact & Investigator
Franziska Sonnauer, Dr. med., M.Sc.
PRINCIPAL INVESTIGATOR
Department of Psychiatry and Psychotherapy, Friedrich-Alexander Universität Erlangen-Nürnberg
Frequently Asked Questions
Who can join the NCT07333027 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Depression Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07333027 currently recruiting?
Yes, NCT07333027 is actively recruiting participants. Contact the research team at franziska.sonnauer@uk-erlangen.de for enrollment information.
Where is the NCT07333027 trial being conducted?
This trial is being conducted at Erlangen, Germany, Erlangen, Germany.
Who is sponsoring the NCT07333027 clinical trial?
NCT07333027 is sponsored by Friedrich-Alexander-Universität Erlangen-Nürnberg. The principal investigator is Franziska Sonnauer, Dr. med., M.Sc. at Department of Psychiatry and Psychotherapy, Friedrich-Alexander Universität Erlangen-Nürnberg. The trial plans to enroll 200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.